| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07110064 | QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic… | Advance Pancreatic Cancer | Recruiting |
| Not specified | |||
| NCT06494514 | NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1… | Locally Advanced Pancreatic Cancer | Recruiting |